2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Kidney Acute Graft Injury

54.40 - The impact of slow and delayed graft function vs. immediate graft function on cadaver renal transplant outcomes

Presenter: MARCIAN ANTONIO, MANU, BUCHAREST, Romania
Authors: SINESCU I., MANU M., HARZA M., SERBANESCU B., STEFAN B., BASTON C., CEREMPEI V., TACU D., KEREZSY E., BUCSA C., DOMNISOR L., DAIA D., BURCHIU E., MANU R., CONSTANTINESCU I.

THE IMPACT OF SLOW AND DELAYED GRAFT FUNCTION VS. IMMEDIATE GRAFT FUNCTION ON CADAVER RENAL TRANSPLANT OUTCOMES

KIDNEY - ACUTE GRAFT INJURY

I. Sinescu1, M.A. Manu1, M. Harza1, B. Serbanescu1, B. Stefan1, C. Baston1, V. Cerempei1, D. Tacu1, E. Kerezsy1, C. Bucsa1, L. Domnisor1, D. Daia1, E. Burchiu1, R. Manu1, I. Constantinescu2
1Urology, Uronephrology & Renal Transplantation Fundeni Clinical Institute, BUCHAREST/ROMANIA, 2Molecular Biology, Immunology And Virusology Laboratory, Fundeni Clinical Institute, BUCHAREST/ROMANIA

Body: Introduction: According to the initial graft function, kidney transplant patients could be divided into three groups: immediate graft function (IGF – postoperative day 5 serum creatinine < 3 mg/day), slow graft function (SGF – day 5 creatinine >3mg/dl, no dialysis) and delayed graft function (DGF – day 5 creatinine >3mg/dl and dialysis). Delayed graft function is a common complication in cadaver kidney transplants sometimes with an arbitrary definition. There is disagreement about the impact of slow and delayed graft function on renal transplant outcomes. Our study was designed to assess the impact of the above three categories in transplant outcomes, and factors involved in first days graft function such was donor age and additional vascular reconstruction. Methods: From June 1997 until March 2010, 1059 renal transplantations (837 living and 222 cadaver, 1003 adults and 56 pediatric transplants) with an average of 83 /year (116 in 2007), were performed in our center. 91 cadaver transplants entered in our study and renal grafts developed function as follows: 64 transplants were IGF, 18 were SGF and 9 DGF. Acute rejection episodes (AR), serum creatinine level and graft survival were analyzed three months, six month and one year after surgery. Young donors and old donors (the edge of 60), normal pedicle and reconstructed pedicle were considered. Results: SGF patients showed worse results considering acute rejection, creatinine level and graft survival in comparison with IGF but better than DGF group. Donor age and additional vascular reconstruction did not significantly modify the outcomes. One year graft survival was better in IGF group than other two groups. Creatinine was worse in SGF group than IGF group – 1.9±0.8 mg/dl vs. 1.4±0.5 mg/dl, but better than DGF group – 2.2±0.7 mg/dl at 12 months, AR rate was 18.75% (12) in IGF group, 38.8% (7) in SGF group and 55.5% (5) in DGF group. Conclusions: Slow graft function has to be considered in appreciation of graft dysfunction. Patients developing SGF have a worse outcome than patients with IGF but similar, or in special cases better than patients developing DGF. Despite they did not need dialysis, SGF patients show worse creatinine level and graft survival and higher acute rejection than IGF. Even mild to moderate post-transplant dysfunction can have a negative impact in graft function and survival.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada